文献速递肾移植

成纤维细胞生长因子23与肾移植结局的关联受随访时长和GFR评估方法影响

The Association Between Fibroblast Growth Factor 23 and Renal Transplantation Outcome Is Modified by Follow-up Duration and Glomerular Filtration Rate Assessment Method.
PubMed 文献 · Kidney Int Rep · 2017-05-18

该队列研究纳入845例病情稳定的肾移植受者,中位随访71个月,分析FGF23与死亡或移植物丢失的关联。高FGF23在单变量分析中与不良结局相关,但校正实测GFR后关联消失;用估算GFR替代时关联仍显著。随访时长也修饰该关联,FGF23测量后4年内与移植物丢失独立相关。

要点

  • 校正实测GFR后,FGF23不是肾移植受者死亡和移植物丢失的独立预测因子。
  • 用估算GFR替代实测GFR时,FGF23与复合结局的关联仍显著。
  • FGF23测量后4年内与移植物丢失存在独立关联。

核心结论

  • 移植后第一年测量的FGF23不是死亡和移植物丢失的独立预测因子,且与左心室肥厚无关。
  • 随访时长和GFR评估方法(实测 vs 估算)会修饰FGF23与结局的关联。

研究设计与样本

  • 分析845例病情稳定的肾移植受者队列,移植后第一年内测量GFR,中位随访71个月。

主要发现

  • 高FGF23在单变量分析中与死亡或移植物丢失相关,校正实测GFR后关联消失。
  • 用估算GFR替代实测GFR时,FGF23仍与复合结局显著相关。
  • FGF23与全研究期间任何终点无关,但与FGF23测量后4年内移植物丢失独立相关。
  • 227例患者在FGF23测量后3个月内行超声心动图,未发现FGF23与左心室质量相关。

临床怎么用

  • 解读肾移植受者FGF23与结局的关联时,需注意GFR评估方法和随访时长的影响。
  • 不应将移植后早期FGF23作为死亡或移植物丢失的独立预测指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Fibroblast growth factor 23 (FGF23) could contribute to cardiovascular morbidity in chronic kidney disease. In studies of kidney transplant recipients, a high circulating level of FGF23 has been associated with death and graft loss independently of estimated glomerular filtration rate (GFR). Whether FGF23 is associated with adverse outcomes in the early posttransplantation period is unknown. METHODS: We analyzed a cohort of 845 kidney transplant recipients in stable condition who had GFR measured in the first years after transplantation with a median follow-up of 71 months. RESULTS: A high FGF23 concentration was associated with death or graft loss in univariate analysis, but this association was lost after adjustment for measured GFR. In contrast, FGF23 remained significantly associated with the composite outcome when estimated GFR was substituted for measured GFR. We also observed that follow-up duration modified the association between FGF23 and outcome. Although FGF23 was not associated with any endpoint in the full duration of the study, we found an independent association between FGF23 and the incidence of graft loss within the 4 years after FGF23 measurement. We did not find an association between FGF23 levels and left ventricular mass in a subgroup of 227 patients who had echocardiography performed within 3 months of FGF23 measurement. DISCUSSION: This study demonstrates that FGF23 measured during the first year after transplantation is not an independent predictor of death and graft loss and is not associated with left ventricular hypertrophy in the posttransplantation period. It further unveils important factors modifying the association between FGF23 and outcome in this population.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Bienaimé F, Dechartres A, Anglicheau D, et al. The Association Between Fibroblast Growth Factor 23 and Renal Transplantation Outcome Is Modified by Follow-up Duration and Glomerular Filtration Rate Assessment Method. Kidney Int Rep. 2017. PMID: 29270495. doi:10.1016/j.ekir.2017.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。